天邁科技(300807.SZ)中標3810萬元福州市公共交通集團有限責任公司公交運營監控調度系統項目
格隆匯 11 月 12日丨天邁科技(300807.SZ)公佈,2020年11月11日,公司收到福州市公共交通集團有限責任公司和福建省機電設備招標有限公司聯合發來的中標通知書,確定公司為福州市公共交通集團有限責任公司公交運營監控調度系統項目的中標人。
項目名稱:福州市公共交通集團有限責任公司公交運營監控調度系統項目;中標金額:3810萬元。
上述項目屬於公司的主營業務,後續若能正式簽訂合同並順利實施,將有利於擴大公司在智能公交領域的市場份額,並對公司的未來經營業績產生積極影響,該項目的履行不影響公司經營的獨立性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.